Publications (297) LEOPOLDO PÉREZ DE ISLA publications

2024

  1. A real-world analysis of adherence, biochemical outcomes, and healthcare costs in patients treated with rosuvastatin/ezetimibe as single-pill combination vs. free combination in Italy

    European Heart Journal Open, Vol. 4, Núm. 5

  2. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

    American Journal of Preventive Cardiology, Vol. 17

  3. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 11, pp. 811-823

  4. Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study

    Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206

  5. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients

    Atherosclerosis, Vol. 392

  6. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy

    Advances in Therapy, Vol. 41, Núm. 8, pp. 3407-3418

  7. Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 9, pp. 484-491

  8. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 9, pp. 643-652

  9. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

  10. Subclinical atherosclerosis burden in carotid and femoral territories in HIV subjects: relationships with HIV and non-HIV related factors

    BMC Infectious Diseases, Vol. 24, Núm. 1

  11. Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: The PANDORA study

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 266-277

2023

  1. Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

    Circulation, Vol. 147, Núm. 19, pp. 1436-1443

  2. Cardiovascular Risk Scores: Great Tools… When Used by Good Physicians

    Revista Argentina de Cardiologia

  3. Cardiovascular Risk Scores: Great Tools… When Used by Good Physicians

    Revista Argentina de Cardiologia

  4. Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)

    European heart journal, Vol. 44, Núm. 2, pp. 113-125

  5. Icosapent ethyl in reducing residual risk. New evidence

    Revista Espanola de Cardiologia Suplementos, Vol. 23, Núm. SA, pp. 15-19

  6. Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

    Neurology and Therapy, Vol. 12, Núm. 5, pp. 1759-1775

  7. Intracoronary thrombus assessment with cardiac computed tomography angiography in a deferred stenting strategy: The MATURE prospective study (MSCT to Assess ThrombUs REsolution)

    Coronary Artery Disease, Vol. 34, Núm. 3, pp. 167-176

  8. Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 320-328

  9. Relevance of subclinical right ventricular dysfunction measured by feature-tracking cardiac magnetic resonance in non-ischemic dilated cardiomyopathy

    BMC Cardiovascular Disorders, Vol. 23, Núm. 1